GBLD-345
Jump to navigation
Jump to search
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
ChEMBL | |
Chemical and physical data | |
Formula | C21H21N5O2 |
Molar mass | 375.432 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
GBLD-345 is an anxiolytic drug used in scientific research, which acts as a non-selective, full-efficacy positive allosteric modulator of the GABAA receptor. It has similar effects to benzodiazepine drugs, but is structurally distinct and so is classed as a nonbenzodiazepine anxiolytic.[1]
References
- ^ Davies LP, Barlin GB, Ireland SJ, Ngu MM (October 1992). "Substituted imidazo[1,2-b]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors". Biochemical Pharmacology. 44 (8): 1555–61. doi:10.1016/0006-2952(92)90472-U. PMID 1358075.
Categories:
- Articles with short description
- Short description matches Wikidata
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Drugboxes which contain changes to watched fields
- Anxiolytics
- Aromatic amines
- Ethers
- Phenol ethers
- Anilines
- GABAA receptor positive allosteric modulators
- All stub articles
- Psychoactive drug stubs